331 related articles for article (PubMed ID: 25854635)
1. Efficacy and tolerability of levetiracetam as adjunctive therapy in Japanese patients with uncontrolled partial-onset seizures.
Inoue Y; Yagi K; Ikeda A; Sasagawa M; Ishida S; Suzuki A; Yoshida K;
Psychiatry Clin Neurosci; 2015 Oct; 69(10):640-8. PubMed ID: 25854635
[TBL] [Abstract][Full Text] [Related]
2. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
[TBL] [Abstract][Full Text] [Related]
3. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
Uthman BM; Almas M; Emir B; Giordano S; Leon T
Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: a randomized, double-blind, noninferiority trial.
Zaccara G; Almas M; Pitman V; Knapp L; Posner H
Epilepsia; 2014 Jul; 55(7):1048-57. PubMed ID: 24902473
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
[TBL] [Abstract][Full Text] [Related]
6. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
[TBL] [Abstract][Full Text] [Related]
7. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
[TBL] [Abstract][Full Text] [Related]
9. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
Glauser TA; Ayala R; Elterman RD; Mitchell WG; Van Orman CB; Gauer LJ; Lu Z;
Neurology; 2006 Jun; 66(11):1654-60. PubMed ID: 16641323
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
[TBL] [Abstract][Full Text] [Related]
11. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial.
Cereghino JJ; Biton V; Abou-Khalil B; Dreifuss F; Gauer LJ; Leppik I
Neurology; 2000 Jul; 55(2):236-42. PubMed ID: 10908898
[TBL] [Abstract][Full Text] [Related]
12. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: a phase IIb, randomized, controlled trial.
Van Paesschen W; Hirsch E; Johnson M; Falter U; von Rosenstiel P
Epilepsia; 2013 Jan; 54(1):89-97. PubMed ID: 22813235
[TBL] [Abstract][Full Text] [Related]
14. Dose-response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy.
Boon P; Chauvel P; Pohlmann-Eden B; Otoul C; Wroe S
Epilepsy Res; 2002 Jan; 48(1-2):77-89. PubMed ID: 11823112
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of levetiracetam: a review of three pivotal clinical trials.
Privitera M
Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
[TBL] [Abstract][Full Text] [Related]
17. The KEEPER trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study.
Morrell MJ; Leppik I; French J; Ferrendelli J; Han J; Magnus L
Epilepsy Res; 2003 May; 54(2-3):153-61. PubMed ID: 12837566
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.
Kwan P; Trinka E; Van Paesschen W; Rektor I; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):38-46. PubMed ID: 24116853
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures.
Klein P; Schiemann J; Sperling MR; Whitesides J; Liang W; Stalvey T; Brandt C; Kwan P
Epilepsia; 2015 Dec; 56(12):1890-8. PubMed ID: 26471380
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of levetiracetam (up to 2000 mg/day) in Taiwanese patients with refractory partial seizures: a multicenter, randomized, double-blind, placebo-controlled study.
Tsai JJ; Yen DJ; Hsih MS; Chen SS; Hiersemenzel R; Edrich P; Lai CW
Epilepsia; 2006 Jan; 47(1):72-81. PubMed ID: 16417534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]